[go: up one dir, main page]

IN2004CH00875A - - Google Patents

Info

Publication number
IN2004CH00875A
IN2004CH00875A IN875CH2004A IN2004CH00875A IN 2004CH00875 A IN2004CH00875 A IN 2004CH00875A IN 875CH2004 A IN875CH2004 A IN 875CH2004A IN 2004CH00875 A IN2004CH00875 A IN 2004CH00875A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Hans-Ulrich Petereit
Christian Meier
Erna Roth
Andreas Gryczke
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of IN2004CH00875A publication Critical patent/IN2004CH00875A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
IN875CH2004 2002-08-27 2004-04-26 IN2004CH00875A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10239999A DE10239999A1 (de) 2002-08-27 2002-08-27 Granulat oder Pulver zur Herstellung von Überzugs- und Bindemitteln für Arzneiformen

Publications (1)

Publication Number Publication Date
IN2004CH00875A true IN2004CH00875A (fr) 2006-01-13

Family

ID=31197526

Family Applications (1)

Application Number Title Priority Date Filing Date
IN875CH2004 IN2004CH00875A (fr) 2002-08-27 2004-04-26

Country Status (16)

Country Link
US (1) US7175857B2 (fr)
EP (1) EP1432409B1 (fr)
JP (1) JP4571861B2 (fr)
KR (1) KR100942667B1 (fr)
AT (1) ATE408401T1 (fr)
AU (1) AU2003266232A1 (fr)
BR (1) BRPI0306143B8 (fr)
CA (1) CA2464502C (fr)
DE (2) DE10239999A1 (fr)
ES (1) ES2314275T3 (fr)
IL (2) IL161145A0 (fr)
IN (1) IN2004CH00875A (fr)
MX (1) MX250472B (fr)
PL (1) PL206233B1 (fr)
SI (1) SI1432409T1 (fr)
WO (1) WO2004019918A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10208344A1 (de) 2002-02-27 2003-09-04 Roehm Gmbh Schmelzextrusion von Wirkstoffsalzen
DE10260921A1 (de) * 2002-12-20 2004-07-01 Röhm GmbH & Co. KG Verfahren zum Überziehen von Substraten für pharmazeutische Anwendungen mit einem Gemisch aus zwei filmbildenden Überzugsmitteln
DE10260920A1 (de) * 2002-12-20 2004-07-01 Röhm GmbH & Co. KG Verfahren zur Herstellung von Arnzeiformen oder Nahrungsergänzungsmitteln mit pigmentierten Polymerüberzügen
DE10260919A1 (de) * 2002-12-20 2004-07-01 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug
DE10304403A1 (de) 2003-01-28 2004-08-05 Röhm GmbH & Co. KG Verfahren zur Herstellung einer oralen Arzneiform mit unmittelbarem Zerfall und Wirkstofffreisetzung
DE102004029573A1 (de) * 2004-06-18 2005-12-29 Gambro Lundia Ab MIF-Adsorbent
WO2006046560A1 (fr) * 2004-10-29 2006-05-04 Taiho Pharmaceutical Co., Ltd. Préparation orale particulaire contenant de la propivérine et procédé de fabrication de ladite préparation
EP1681049A1 (fr) * 2005-01-12 2006-07-19 Physica Pharma Composition pharmaceutique et forme galénique correspondante à délitement rapide en bouche, et procédé de fabrication de cette composition
US20060264458A1 (en) * 2005-05-03 2006-11-23 Jie Du Quinine dosage forms and methods of use thereof
DE102005042039A1 (de) * 2005-09-02 2007-03-08 Basf Ag Wässrige Polyvinylacetatdispersionen mit hoher Scherstabilität
PT2046300E (pt) * 2006-08-04 2010-07-01 Ethypharm Sa Comprimido multicamadas de desintegraã†o oral
WO2009016258A1 (fr) 2007-08-02 2009-02-05 Basf Se Dispersion polymère aqueuse à base de n,n-diéthylaminoéthylméthacrylate, mode de production et utilisation correspondants
US20100062062A1 (en) * 2008-09-11 2010-03-11 Aethos Pharmaceuticals, Inc. Stabilized Coating for Pharmaceutical Formulations
US9254329B2 (en) 2009-10-28 2016-02-09 Basf Se Stable protective coatings for pharmaceutical dosage forms
US20110150986A1 (en) * 2009-12-18 2011-06-23 Kristin Arnold Quinine formulations, method of making, and metho of use thereof
BR112012022775A2 (pt) * 2010-03-10 2016-07-19 Nogra Pharma Ltd composições para a lavagem, do cólon e métodos para a produção e utilização das mesmas
ES2688278T3 (es) * 2010-05-10 2018-10-31 Evonik Röhm Gmbh Forma de dosificación farmacéutica que comprende uno o más ingredientes activos antirretrovirales
WO2012031934A1 (fr) 2010-09-07 2012-03-15 Basf Se Utilisation de copolymères à base de polymères contenant des groupes amino en tant que liants matriciels pour la fabrication de granulés contenant des agents actifs et formes galéniques
CN103221038B (zh) 2010-09-27 2019-05-07 巴斯夫欧洲公司 酸性活性成分的保护涂层
US9795576B2 (en) 2010-09-27 2017-10-24 Basf Se Protective coatings for acidic active ingredients
CN103347931B (zh) 2011-02-28 2016-02-17 巴斯夫欧洲公司 制备用于药物剂型的稳定保护性衣层的粉末包衣剂
US8865250B2 (en) 2011-02-28 2014-10-21 Basf Se Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms
US8962064B2 (en) 2011-02-28 2015-02-24 Basf Se Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms
BR112013021510B1 (pt) 2011-02-28 2020-09-24 Basf Se Processo para a produção de composições de revestimento em pó, e, uso de um pó de polímero
US9044734B2 (en) 2011-09-23 2015-06-02 Basf Se Diesel oxidation catalyst with layered structure containing ceria composition as palladium support material for enhanced HC and CO gas conversion
US20130236505A1 (en) 2012-03-09 2013-09-12 Basf Se Production Of Pharmaceutical Protective Coatings With Good Resistance In A Neutral Environment
EP2636403A1 (fr) * 2012-03-09 2013-09-11 Basf Se Fabrication de revêtements de protection pharmaceutiques ayant une bonne résistance en milieu neutre
US10668156B2 (en) 2012-06-22 2020-06-02 Basf Se Active-ingredient-containing solid dispersions based on diethylaminoethyl methacrylate copolymers
WO2013189776A1 (fr) 2012-06-22 2013-12-27 Basf Se Dispersions solides renfermant des principes actifs à base de compolymères de diéthylaminoéthylméthacrylate
WO2014079592A1 (fr) * 2012-11-22 2014-05-30 Evonik Industries Ag Procédé pour la préparation d'un produit granulé à partir d'une composition de poudre
FR3027802B1 (fr) * 2014-10-31 2018-03-02 Ethypharm Granules de principe actif a double masquage de gout, leur procede de preparation et comprimes orodispersibles les contenant
GR1008992B (el) * 2015-12-17 2017-03-23 Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων Φαρμακευτικη συνθεση σε μορφη κοκκιων για χορηγηση απο το στομα που περιεχει μετρονιδαζολη ή παραγωγα αυτης και εναν παραγοντα καλυψης της γευσης
EP3569225A1 (fr) * 2018-05-18 2019-11-20 Pharmaceutical Oriented Services Ltd Dispersion solide contenant du ritonavir
JP7058763B2 (ja) * 2018-12-27 2022-04-22 興和株式会社 医薬品
CN116887866A (zh) 2020-12-03 2023-10-13 巴特尔纪念研究院 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法
JP2024516108A (ja) 2021-04-07 2024-04-12 バテル・メモリアル・インスティテュート 非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術
WO2025072751A1 (fr) 2023-09-29 2025-04-03 Battelle Memorial Institute Compositions de nanoparticules polymères pour l'expression in vivo de polypeptides
WO2025122954A1 (fr) 2023-12-08 2025-06-12 Battelle Memorial Institute Utilisation de nanostructures d'origami d'adn pour systèmes de stockage de données basés sur des informations moléculaires

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0164669B1 (fr) * 1984-06-13 1991-01-23 Röhm Gmbh Procédé pour enrober des formes pharmaceutiques
DE3920082A1 (de) * 1989-06-20 1991-03-07 Roehm Gmbh Filmbildendes waessriges ueberzugsmittel fuer feste arzneimittel, verfahren zu seiner herstellung und verwendung
DE29502547U1 (de) * 1995-02-16 1995-03-30 Röhm GmbH, 64293 Darmstadt Thermoplastisches Überzugs- und Bindemittel für Arzneiformen
DE19918435A1 (de) * 1998-07-23 2000-01-27 Roehm Gmbh Überzugs- und Bindemittel für orale oder dermale Arzneiformen
DE19958007A1 (de) * 1999-12-02 2001-06-07 Roehm Gmbh Spritzgußverfahren für (Meth)acrylat-Copolymere mit teritiären Ammoniumgruppen
JP4663957B2 (ja) * 2000-07-14 2011-04-06 ベリデックス・リミテッド・ライアビリティ・カンパニー 磁性ナノ粒子の制御された凝集による増大した分離効率
KR100510356B1 (ko) * 2001-02-27 2005-08-24 룀 게엠베하 운트 콤파니 카게 저장 안정성이 개선된 피복제 및 결합제를 포함하는 약제학적 제형 및 이의 제조방법
DE10208344A1 (de) * 2002-02-27 2003-09-04 Roehm Gmbh Schmelzextrusion von Wirkstoffsalzen

Also Published As

Publication number Publication date
US7175857B2 (en) 2007-02-13
MX250472B (es) 2007-10-17
CA2464502A1 (fr) 2004-03-11
JP4571861B2 (ja) 2010-10-27
EP1432409B1 (fr) 2008-09-17
CA2464502C (fr) 2010-11-23
ATE408401T1 (de) 2008-10-15
WO2004019918A1 (fr) 2004-03-11
PL368186A1 (en) 2005-03-21
DE50310506D1 (de) 2008-10-30
US20040249035A1 (en) 2004-12-09
BRPI0306143B8 (pt) 2021-05-25
KR20050034620A (ko) 2005-04-14
DE10239999A1 (de) 2004-03-04
JP2005536555A (ja) 2005-12-02
MXPA04003970A (es) 2004-06-22
US20050197434A9 (en) 2005-09-08
ES2314275T3 (es) 2009-03-16
IL161145A0 (en) 2004-08-31
EP1432409A1 (fr) 2004-06-30
PL206233B1 (pl) 2010-07-30
BR0306143A (pt) 2004-10-19
IL161145A (en) 2010-11-30
BRPI0306143B1 (pt) 2016-03-08
SI1432409T1 (sl) 2009-02-28
AU2003266232A1 (en) 2004-03-19
KR100942667B1 (ko) 2010-02-17

Similar Documents

Publication Publication Date Title
BE2019C547I2 (fr)
BE2019C510I2 (fr)
BE2018C021I2 (fr)
BE2016C013I2 (fr)
BE2015C078I2 (fr)
BE2016C002I2 (fr)
BE2015C017I2 (fr)
BE2014C053I2 (fr)
BE2014C051I2 (fr)
BE2014C041I2 (fr)
BE2014C030I2 (fr)
BE2014C016I2 (fr)
BE2014C015I2 (fr)
BE2013C063I2 (fr)
BE2013C039I2 (fr)
JP2003163282A5 (fr)
IN2004CH00875A (fr)
BE2015C067I2 (fr)
JP2002335878A5 (fr)
JP2003162975A5 (fr)
BE2013C046I2 (fr)
JP2003210060A5 (fr)
JP2003187505A5 (fr)
JP2003205156A5 (fr)
BR0315835A2 (fr)